Zolpidem Tartrate is a sedative-hypnotic agent belonging to the imidazopyridine class, indicated for the short-term treatment of insomnia, specifically for patients experiencing difficulties with sleep… Read more
![Chemical structure of 1-(1H-Imidazol-1-yl)-2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)ethan-1-one (PSY)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-1H-Imidazol-1-yl-2-6-methyl-2-p-tolylimidazo12-apyridin-3-ylethan-1-one-PSY.png&w=3840&q=75)

![Chemical structure of Ethyl 2-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)acetate (PSY)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F193979-47-4-Ethyl-2-6-methyl-2-p-tolylimidazo12-apyridin-3-ylacetate-PSY.png&w=3840&q=75)









Zolpidem Tartrate is a sedative-hypnotic agent belonging to the imidazopyridine class, indicated for the short-term treatment of insomnia, specifically for patients experiencing difficulties with sleep initiation. By enhancing the activity of gamma-aminobutyric acid receptors, the drug promotes drowsiness and sleep maintenance. Laboratories require precise reference standards to ensure the efficacy and safety of pharmaceutical products during manufacturing and regulatory testing. This collection includes high-quality Zolpidem Tartrate API, alongside a comprehensive selection of process-related impurities, synthesis intermediates, and degradation products. These materials are essential for rigorous impurity profiling, analytical method development, and the validation of quality control procedures. Additionally, stable isotope labelled compounds are available to serve as reliable internal standards in mass spectrometry-based assays, facilitating accurate quantification and identification throughout the drug development lifecycle.